Literature DB >> 35899284

Nocardia beijingensis Isolated From an Adrenal Abscess in a Diabetic Host.

Melissa Pender1, Ninad Mehta2, Blake D Hamilton3, Sankar Swaminathan1.   

Abstract

We describe the case of a 57-year-old man with poorly controlled type 2 diabetes mellitus who presented with 30 days of left-sided abdominal pain. He was found to have a left adrenal abscess and underwent adrenalectomy. Intraoperative cultures grew Nocardia beijingensis, which is an uncommonly identified Nocardia species rarely affecting immunocompetent patients. We review the published literature on cases of N beijingensis among immunocompetent patients. This is the first report summarizing the diagnosis and management of N beijingensis isolated from an adrenal abscess.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Entities:  

Keywords:  Nocardia beijingensis; adrenal abscess; diabetes

Year:  2022        PMID: 35899284      PMCID: PMC9310264          DOI: 10.1093/ofid/ofac328

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN: 2328-8957            Impact factor:   4.423


Nocardia species are aerobic actinomycetes found in the soil; these organisms are pyogenic bacteria with a predilection for abscess formation and extension into surrounding tissues [1-3]. To date, 54 of the 92 identified Nocardia spp have been documented to cause human disease [4], with infections occurring primarily among immunocompromised patients [1, 3]. Species are identified and differentiated using 16S ribosomal ribonucleic acid (rRNA) gene sequencing [5, 6]. Wang et al first isolated Nocardia beijingensis from a soil sample in China in 2001 [5]. Nocardia beijingensis has subsequently been identified as a rare cause of infection primarily affecting immunocompromised hosts [7-12]. Our case represents the first published report of N beijingensis isolated from an adrenal gland.

CASE REPORT

A 57-year-old man was admitted to the hospital for evaluation of progressive left upper quadrant abdominal pain over the past month. Additional symptoms included subjective fevers, diaphoresis, tachycardia, anorexia, nausea, a 6.8-kg (15-lb) weight loss, and several episodes of nonbloody, nonbilious vomiting. Prior to onset of abdominal pain, the patient was asymptomatic and physically active. His medical history included hypertension and diabetes mellitus type 2 with a hemoglobin A1c of 10%. He had no history of trauma or intra-abdominal procedures. He was a former smoker with a 25 pack-year smoking history and had no other relevant substance use history. The patient lived in a medium-sized town within a largely rural Wyoming community and had no international travel history. He had no animal exposures. He reported riding his motorcycle in the Rocky Mountain area and described associated dust inhalation. At the time of initial evaluation, vital signs demonstrated a temperature of 96.6°C, heart rate of 123 beats per minute, blood pressure of 170/115 mm Hg, and normal oxygenation on room air. He described 9/10 left upper quadrant abdominal pain but lacked evidence of peritonitis, and his abdomen was not tender. An abdominal computed tomographic (CT) scan revealed a 9 × 4.2-cm heterogenous left adrenal mass (Figure 1). Laboratory evaluation demonstrated leukocytosis of 18 000 cells/µL. Normal levels of plasma free metanephrines ruled out pheochromocytoma. Chest radiographs showed a possible left-sided infiltrate with parapneumonic effusion, and cefuroxime was administered for 5 days to treat presumed community-acquired pneumonia.
Figure 1.

Abdominal computed tomographic scan highlighting a 9 × 4.2-cm heterogenous left adrenal mass (circled in white).

Abdominal computed tomographic scan highlighting a 9 × 4.2-cm heterogenous left adrenal mass (circled in white). The patient underwent robot-assisted left adrenalectomy on day 10 of admission with concern for malignant disease. Purulent drainage from the left adrenal gland was observed during surgery. Perinephric fat was sent for tissue culture. The patient remained clinically stable by postoperative day 2, and he was discharged home with a 5-day course of amoxicillin-clavulanic acid. Gram stain of the tissue sent for culture showed 1+ polymorphonuclear leukocytes without organisms. On postoperative day 3, blood and chocolate agar plates grew Nocardia spp in aerobic culture subsequently identified by 16s rRNA sequencing as N beijingensis (Figure 2). Sequencing was performed at a reference laboratory (ARUP Laboratories, Salt Lake City, Utah) and analyzed using the RipSeq database [13] with a 98.45% identification match to N beijingensis. The organism demonstrated susceptibility to trimethoprim-sulfamethoxazole (TMP-SMX), linezolid, carbapenems, tetracyclines, amoxicillin-clavulanic acid, and third-/fourth-generation cephalosporins with resistance only to fluoroquinolones. Pathology of the left adrenal mass was negative for neoplasm and demonstrated acute and chronic inflammation including prominent neutrophils and macrophages. Gram stain demonstrated filamentous micro-organisms on routine hematoxylin-eosin stain and modified acid-fast stain.
Figure 2.

Partially acid-fast gram-positive bacilli grew from resected adrenal tissue on chocolate agar after 48 hours and is pictured at ×1000 magnification. The typical beaded appearance is evident at the periphery of the field.

Partially acid-fast gram-positive bacilli grew from resected adrenal tissue on chocolate agar after 48 hours and is pictured at ×1000 magnification. The typical beaded appearance is evident at the periphery of the field. After confirming organism susceptibilities, the patient began treatment with TMP-SMX 320 mg/1600 mg twice daily and linezolid 600 mg twice daily. Given the propensity of Nocardia to invade the brain and pulmonary systems [3], magnetic resonance imaging of his brain and a CT scan of his chest were performed. His brain imaging did not show intracranial pathology. Chest imaging demonstrated multiple small calcified pulmonary granulomas with several subcentimeter noncalcified nodules that were unchanged on repeat imaging 4 months later. He received linezolid for 3 months before this was discontinued due to thrombocytopenia, and he received TMP-SMX for a total of 7 months targeting visceral and suspected pulmonary nocardiosis. The patient recovered and remained without signs of recurrent disease at time of publication, >7 months from his last treatment dose.

DISCUSSION

Systemic nocardiosis remains a rare presentation among immunocompetent patients, particularly among those with no prior history of surgery, injection drug use, or trauma. Whereas pulmonary nocardiosis is associated with dust inhalation or aspiration [14], extrapulmonary disease results from traumatic inoculation or hematogenous spread from a primary site of infection [2]. Nocardiosis occurs primarily among immunocompromised hosts with approximately one-third of infections occurring among immunocompetent patients [1, 2]. Diabetes mellitus, while not a primary cause of immunodeficiency, can increase risk of infections through the effect of hyperglycemia on the immune system and is considered a secondary cause of immunodeficiency [15, 16]. While still considered relatively immunocompetent, our patient’s poorly controlled diabetes may have increased his risk for systemic nocardiosis through impaired phagocytosis, chemotaxis, and/or decreased mitogen-induced lymphoproliferation [15]. We suspect this patient’s N beijingensis infection began as primary pulmonary nocardiosis with subsequent hematogenous spread to the left adrenal gland. Chronic lung disease and cigarette smoking have been identified as risk factors for nocardiosis [17, 18]. The nodules on chest imaging likely represent sites of infection, although he remained free of pulmonary symptoms. His only identified exposure risk was dust inhalation while riding his motorcycle. Saubolle and Sussland [14] hypothesize that dry, windy conditions facilitate Nocardia aerosolization, leading to inhalation and pulmonary infection. Nocardia beijingensis was first isolated from a soil sample in China in 2001 [5]. Human infections with this species have been identified as early as 2004 among immunocompromised patients in Japan and Thailand [7]. There have been few documented cases in the Western Hemisphere [9]. In 2014, Crozier et al reported the first case affecting an immunocompetent patient in the United States [12]. To date, there are 8 previously published reports of N beijingensis affecting immunocompetent individuals. As in infections with other Nocardia spp, pulmonary and central nervous system (CNS) disease are most commonly reported. A literature review of N beijingensis infections in immunocompetent hosts yielded 3 documented pulmonary cases [12, 19–21], 2 cases of CNS abscesses [22, 23], 1 overlap case presenting with both pulmonary and CNS disease [24], 1 case of a subfascial paravertebral abscess [25], and 1 case of scleritis [26] (Table 1).
Table 1.

Published Reports of Nocardia beijingensis Infections Among Immunocompetent Hosts

Study [Reference]Sex, AgeComorbidities or Potential Risk FactorsSymptomsInfection SiteTreatment
Crozier et al, 2014 [12]M, 48 yCotton farmerCough, fevers, night sweats, weight loss for 1 moPulmonary: hilar massCeftriaxone for 6 wk; TMP-SMX for 6 mo
Rigotti et al, 2015 [25]M, 75 yNone identifiedLower back pain, abdominal pain, constipation for 10 wkParavertebral abscess L3–L5Imipenem-cilastatin + amikacin for 3 wk; TMP-SMX for 3 mo
Abdel-Rahman et al, 2015 [19]F, 55 yBreast cancer treated surgically 9 y earlierFever, cough, hemoptysis for 6 moPulmonary: endobronchial massCeftriaxone for 4 wk; TMP-SMX for 3 mo
Gonzalez et al, 2016 [26]F, 52 yContact lens useRight eye pain, redness, photophobia for 8 wkScleritisTMP-SMX + topical amikacin + topical polymyxin-trimethoprim for 10 mo
Solano-Varela et al, 2019 [22]M, 58 yNone identifiedHeadache, right hemiparesis for 6 moCNS: left thalamic abscessMeropenem + amikacin + TMP-SMX
Tanaka et al, 2020 [23]M, 68 yPetrochemical plant employeeAnorexia for 1 mo, acute headache and vomitingCNS: miliary cerebrospinal abscessesMeropenem + TMP-SMX for 4 wk; TMP-SMX for 7 mo
Roy et al, 2020 [24]F, 57 yNone identifiedAcute seizurePulmonary: left upper lobe mass, CNS: right temporal abscessTMP-SMX for 12 mo
Raslan et al, 2021 [21]M, 47 yNone identifiedLung mass identified on imagingPulmonary: lung massTMP-SMX + doxycycline (duration unspecified)
Present caseM, 57 ySmoker, dust inhalation riding a motorcycle, type 2 diabetesAbdominal pain, fevers, nausea, weight loss for 1 moAbdominal: Left adrenal abscessLinezolid for 3 mo + TMP-SMX for 7 mo

Abbreviations: CNS, central nervous system; F, female; M, male; TMP-SMX, trimethoprim-sulfamethoxazole.

Published Reports of Nocardia beijingensis Infections Among Immunocompetent Hosts Abbreviations: CNS, central nervous system; F, female; M, male; TMP-SMX, trimethoprim-sulfamethoxazole. Identification of Nocardia spp remains an important step in treatment as antimicrobial susceptibility patterns vary between species. Most documented N beijingensis infections have responded to treatment with TMP-SMX, carbapenems, amikacin, and/or third-generation cephalosporins [24], although imipenem nonsusceptibility has been observed in 1 example [26]. As there are no available trials to guide the treatment of Nocardia infections, the recommended duration of therapy for systemic nocardiosis is typically 6–12 months based on expert opinion [3, 17, 27]. Given the surgical resection of our patient’s abscess and subsequent clinical improvement, we elected to treat him for a 7-month course with TMP-SMX. In conclusion, we describe a case of adrenal nocardiosis caused by N beijingensis masquerading as malignant disease This pathogen has not previously been described from an adrenal site.
  27 in total

Review 1.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

Review 2.  Nocardiosis.

Authors:  P I Lerner
Journal:  Clin Infect Dis       Date:  1996-06       Impact factor: 9.079

3.  Nocardiosis: 7-year experience at an Australian tertiary hospital.

Authors:  Emma K Paige; Denis Spelman
Journal:  Intern Med J       Date:  2019-03       Impact factor: 2.048

4.  Isolation of Nocardia beijingensis from a pulmonary abscess reveals human immunodeficiency virus infection.

Authors:  Christophe Martinaud; Charles Verdonk; Aurore Bousquet; Christine Macnab; Fabien Vaylet; Charles Soler; Thierry Samson; Jacques Margery
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

5.  Nocardia beijingensis lung mass in an immunocompetent adult.

Authors:  Rasha Raslan; Pamela Bailey; Sangeeta Sastry
Journal:  BMJ Case Rep       Date:  2021-01-26

6.  Susceptibility profiles of Nocardia isolates based on current taxonomy.

Authors:  Robert Schlaberg; Mark A Fisher; Kimberley E Hanson
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

7.  The first case of Nocardia beijingensis isolated infection to lumbar spine.

Authors:  Stefano Rigotti; Stefania Marocco; Andrea Angheben; Daniele Screpis; Gianluca Piovan; Claudio Zorzi
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

8.  Endobronchial Enigma: A Clinically Rare Presentation of Nocardia beijingensis in an Immunocompetent Patient.

Authors:  Nader Abdel-Rahman; Shimon Izhakian; Walter G Wasser; Oren Fruchter; Mordechai R Kramer
Journal:  Case Rep Pulmonol       Date:  2015-12-24

9.  Disseminated Nocardia beijingensis Infection in an Immunocompetent Patient.

Authors:  Moni Roy; Annia Martial; Sharjeel Ahmad
Journal:  Eur J Case Rep Intern Med       Date:  2020-09-09

10.  Miliary cerebrospinal lesions caused by Nocardia beijingensis in an immunocompetent patient.

Authors:  Hajime Tanaka; Katsunari Kiko; Yudai Watanabe; Takashi Yaguchi; Shigeru Oya; Toshiaki Shiojiri
Journal:  IDCases       Date:  2020-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.